Expert Briefing: Mental Well-being and Memory
Gregory Pontone, MD, MHS
Director, Parkinson’s Neuropsychiatry Clinical Programs
Johns Hopkins University School of Medicine
Morris K. Udall Parkinson's Disease Research Center
Departments of Psychiatry and Neurology
Lisa Cone was diagnosed with Parkinson’s Disease in 2008 at the age of 45. Since taking an early retirement from her work as an executive leader in Healthcare Services, she uses those professional experiences and her personal experience in her work as a volunteer Patient Advocate. She has been a Parkinson's Advocate in Research (PAIR) for the Parkinson’s Foundation since 2015 and was a participant in the Women in PD study. Lisa has co-authored two published research articles and is active in advancing patient-focused public policy issues. She was appointed to the People with Parkinson’s Advisory Council in July of 2020 and will serve a three year term. She lives near Denver with her husband and three dogs.
3 Learning Objectives
1) Describe normal, age-related, cognitive changes and strategies to stay well
2) Discuss the medications that may cause cognitive impairment in PD
3) Review how PD may affect cognition as it progresses over time
In this Expert Briefing, neuropsychiatrist, Gregory Pontone, MD, MHS, and Lisa Cone who is living with Parkinson's disease discuss tips to stay mentally well, how Parkinson’s progression affects cognition, along with treatments for cognitive impairment and dementia in Parkinson’s.
Gregory Pontone, M.D., M.H.S. Gregory Pontone, M.D., M.H.S. is an Associate Professor and Director of the Parkinson's disease Neuropsychiatry Clinic in the Departments of Psychiatry and Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. After completing a medicine internship and residency training in psychiatry at Johns Hopkins, Dr. Pontone completed a two-year fellowship in geriatric psychiatry and movement disorders focusing on Parkinson’s disease through the Clinical Research Program of the Morris K. Udall Parkinson’s Disease Research Center at Johns Hopkins.
The Winter/Spring 2021 Expert Briefings Series was made possible by the generous support of Theravance Biopharma.